Cargando…
Immunogenicity and protective efficacy of recombinant alkaline shock protein 23 from Staphylococcus aureus in a murine model
The diversity and severity of infections caused and the rapid emergence of antibiotic resistance necessitates the development of a vaccine against Staphylococcus aureus. None of the antigens tried as vaccine candidates so far has been translated into a clinically viable vaccine. Recent research data...
Autores principales: | Francis, Dileep, Kuyyalil, Surekha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Polish Society of Experimental and Clinical Immunology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384426/ https://www.ncbi.nlm.nih.gov/pubmed/30799984 http://dx.doi.org/10.5114/ceji.2018.81348 |
Ejemplares similares
-
Safety and Immunogenicity of a 4-Component Toxoid-Based Staphylococcus aureus Vaccine in Rhesus Macaques
por: Venkatasubramaniam, Arundhathi, et al.
Publicado: (2021) -
Tissue specificity drives protective immunity against Staphylococcus aureus infection
por: Beesetty, Pavani, et al.
Publicado: (2022) -
Staphylococcus aureus δ-toxin present on skin promotes the development of food allergy in a murine model
por: Yamada, Hiromichi, et al.
Publicado: (2023) -
Preconditioning with Lipopolysaccharide or Lipoteichoic Acid Protects against Staphylococcus aureus Mammary Infection in Mice
por: Breyne, Koen, et al.
Publicado: (2017) -
Immunodominance of Epitopes and Protective Efficacy of HI Antigen Are Differentially Altered Using Different Adjuvants in a Mouse Model of Staphylococcus aureus Bacteremia
por: Chen, Zhifu, et al.
Publicado: (2021)